RA CAPITAL MANAGEMENT, LLC Insider Trading Transactions
Get free email notifications about insider trading for RA CAPITAL MANAGEMENT, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RA CAPITAL MANAGEMENT, LLC. RA CAPITAL MANAGEMENT, LLC is 10% Owner in LIPID SCIENCES INC/ ($LIPD) and 10% Owner in TG THERAPEUTICS, INC. ($TGTX) and Director in KalVista Pharmaceuticals, Inc. ($CBYL) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and Director in Dicerna Pharmaceuticals Inc ($DRNA) and Director in Kala Pharmaceuticals, Inc. ($KALA) and Director in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in Verastem, Inc. ($VSTM) and 10% Owner in Forma Therapeutics Holdings, Inc., ($FMTX) and 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and in G1 Therapeutics, Inc. ($GTHX) and 10% Owner in Synthorx, Inc. ($THOR) and 10% Owner in scPharmaceuticals Inc. ($SCPH) and Director in Wave Life Sciences Ltd. ($WVE) and 10% Owner in Vaxcyte, Inc. ($PCVX) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and in ARVINAS INC. ($ARVN) and 10% Owner in Iterum Therapeutics plc ($ITRM) and 10% Owner in IMARA Inc. ($IMRA) and Director in Satsuma Pharmaceuticals, Inc. ($STSA) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in PMV Pharmaceuticals, Inc. ($PMVP) and Director in Solid Biosciences Inc. ($SLDB) and Director in Eidos Therapeutics, Inc. ($EIDX) and 10% Owner in Inhibrx, Inc. ($INBX) and 10% Owner in Orchard Therapeutics plc ($ORTX) and Director in Orchard Therapeutics plc ($ORTX) and Director in Werewolf Therapeutics, Inc. ($HOWL) and 10% Owner in Nkarta, Inc. ($NKTX) and Director in Nkarta, Inc. ($NKTX) and 10% Owner in Phathom Pharmaceuticals, Inc. ($PHAT) and Director in 89bio, Inc. ($ETNB) and 10% Owner in Pandion Therapeutics, Inc. ($PAND) and 10% Owner in iTeos Therapeutics, Inc. ($ITOS) and Director in iTeos Therapeutics, Inc. ($ITOS) and Director in Vor Biopharma Inc. ($VOR) and 10% Owner in Dyne Therapeutics, Inc. ($DYN).
Latest Insider Trading Transactions of RA CAPITAL MANAGEMENT, LLC
Sentiment: All, ETNB, ACRS, ARVN, DRNA, DYN, EIDX, FMTX, GTHX, IMRA, INBX, INZY, ITOS, ITRM, KALA, KALV, LIPD, NKTX, ORTX, PAND, PHAT, PMVP, RARX, RYTM, STSA, SCPH, SLDB, THOR, TGTX, PCVX, VSTM, VOR, WVE, HOWL
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 23 2016 | CBYL | KalVista Pharmaceu ... | RA CAPITAL MANAGEMENT, LLC | Director | Grant | A | 0.00 | 591,070 | 0 | 591,070 | 0 to 591.1 K |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | RA CAPITAL MANAGEMENT, LLC | Director | Option Exercise | C | 0.00 | 4,015,378 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | RA CAPITAL MANAGEMENT, LLC | Director | Option Exercise | C | 0.00 | 4,316,531 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | RA CAPITAL MANAGEMENT, LLC | Director | Buy | P | 13.00 | 161,538 | 2,099,994 | 1,351,808 | 1.2 M to 1.4 M (+13.57 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | RA CAPITAL MANAGEMENT, LLC | Director | Buy | C | 0.00 | 573,624 | 0 | 1,190,270 | 616.6 K to 1.2 M (+93.02 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | RA CAPITAL MANAGEMENT, LLC | Director | Buy | C | 0.00 | 616,646 | 0 | 616,646 | 0 to 616.6 K |
Sep 19 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 24.54 | 23,600 | 579,212 | 2,102,169 | 2.1 M to 2.1 M (-1.11 %) |
Sep 19 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 24.50 | 150,000 | 3,675,000 | 2,125,769 | 2.3 M to 2.1 M (-6.59 %) |
Sep 19 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 24.20 | 58,950 | 1,426,590 | 2,275,769 | 2.3 M to 2.3 M (-2.52 %) |
Sep 19 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 24.00 | 273,000 | 6,552,000 | 2,334,719 | 2.6 M to 2.3 M (-10.47 %) |
Sep 19 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 24.04 | 20,000 | 480,700 | 2,607,719 | 2.6 M to 2.6 M (-0.76 %) |
Feb 24 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 17.62 | 28,408 | 500,512 | 2,627,719 | 2.6 M to 2.6 M (+1.09 %) |
Feb 24 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 15.99 | 11,318 | 180,958 | 2,599,311 | 2.6 M to 2.6 M (+0.44 %) |
Jan 20 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 19.88 | 1,803 | 35,849 | 2,587,993 | 2.6 M to 2.6 M (+0.07 %) |
Jan 20 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 19.88 | 4,200 | 83,480 | 2,586,190 | 2.6 M to 2.6 M (+0.16 %) |
Jan 20 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 19.86 | 1,800 | 35,743 | 2,581,990 | 2.6 M to 2.6 M (+0.07 %) |
Jan 13 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 19.97 | 5,543 | 110,674 | 2,580,190 | 2.6 M to 2.6 M (+0.22 %) |
Jan 13 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 19.12 | 5,941 | 113,585 | 2,574,647 | 2.6 M to 2.6 M (+0.23 %) |
Jan 13 2016 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 17.93 | 4,153 | 74,479 | 2,568,706 | 2.6 M to 2.6 M (+0.16 %) |
Nov 18 2015 | WVE | Wave Life Sciences ... | RA CAPITAL MANAGEMENT, LLC | Director | Option Exercise | C | 0.00 | 1,172,060 | 0 | 0 | |
Nov 18 2015 | WVE | Wave Life Sciences ... | RA CAPITAL MANAGEMENT, LLC | Director | Option Exercise | P | 0.00 | 1,172,060 | 0 | 1,172,060 | |
Nov 18 2015 | WVE | Wave Life Sciences ... | RA CAPITAL MANAGEMENT, LLC | Director | Buy | P | 16.00 | 1,875,000 | 30,000,000 | 7,088,651 | 5.2 M to 7.1 M (+35.96 %) |
Nov 18 2015 | WVE | Wave Life Sciences ... | RA CAPITAL MANAGEMENT, LLC | Director | Buy | C | 0.00 | 1,172,060 | 0 | 5,213,651 | 4 M to 5.2 M (+29.00 %) |
Oct 30 2015 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 14.00 | 95,000 | 1,330,000 | 2,564,552 | 2.5 M to 2.6 M (+3.85 %) |
Oct 30 2015 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 14.00 | 149,200 | 2,088,800 | 2,469,552 | 2.3 M to 2.5 M (+6.43 %) |
Oct 26 2015 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 14.03 | 5,410 | 75,883 | 2,320,352 | 2.3 M to 2.3 M (+0.23 %) |
Oct 21 2015 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 14.83 | 3,100 | 45,976 | 2,314,942 | 2.3 M to 2.3 M (+0.13 %) |
Oct 21 2015 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 14.95 | 7,965 | 119,070 | 2,311,842 | 2.3 M to 2.3 M (+0.35 %) |
Oct 21 2015 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 14.88 | 23,934 | 356,049 | 2,303,877 | 2.3 M to 2.3 M (+1.05 %) |
Oct 16 2015 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 14.06 | 42,813 | 601,792 | 2,279,943 | 2.2 M to 2.3 M (+1.91 %) |
Oct 13 2015 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 11.00 | 21,691 | 238,555 | 2,237,130 | 2.2 M to 2.2 M (+0.98 %) |
Oct 13 2015 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 11.00 | 27,398 | 301,378 | 2,215,439 | 2.2 M to 2.2 M (+1.25 %) |
Oct 13 2015 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 11.00 | 1,250,000 | 13,750,000 | 2,188,041 | 938 K to 2.2 M (+133.26 %) |
Oct 13 2015 | ACRS | Aclaris Therapeuti ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 10.66 | 938,041 | 9,999,986 | 938,041 | 0 to 938 K |
Mar 28 2007 | LIPD | LIPID SCIENCES INC ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 1.40 | 300 | 420 | 3,713,962 | 3.7 M to 3.7 M (+0.01 %) |
Dec 29 2006 | LIPD | LIPID SCIENCES INC ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 1.57 | 1,600 | 2,512 | 3,662,662 | 3.7 M to 3.7 M (-0.04 %) |
Dec 29 2006 | LIPD | LIPID SCIENCES INC ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 1.56 | 3,100 | 4,836 | 3,664,262 | 3.7 M to 3.7 M (-0.08 %) |
Dec 29 2006 | LIPD | LIPID SCIENCES INC ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 1.55 | 20,400 | 31,620 | 3,667,362 | 3.7 M to 3.7 M (-0.55 %) |
Dec 29 2006 | LIPD | LIPID SCIENCES INC ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 1.54 | 9,204 | 14,174 | 3,687,762 | 3.7 M to 3.7 M (-0.25 %) |
Dec 29 2006 | LIPD | LIPID SCIENCES INC ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 1.53 | 100 | 153 | 3,696,966 | 3.7 M to 3.7 M (0.00 %) |
Dec 29 2006 | LIPD | LIPID SCIENCES INC ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 1.52 | 900 | 1,368 | 3,697,066 | 3.7 M to 3.7 M (-0.02 %) |
Dec 29 2006 | LIPD | LIPID SCIENCES INC ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 1.51 | 100 | 151 | 3,697,966 | 3.7 M to 3.7 M (0.00 %) |
Dec 29 2006 | LIPD | LIPID SCIENCES INC ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 1.50 | 15,442 | 23,163 | 3,698,066 | 3.7 M to 3.7 M (-0.42 %) |
Dec 29 2006 | LIPD | LIPID SCIENCES INC ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 1.47 | 900 | 1,323 | 3,713,508 | 3.7 M to 3.7 M (-0.02 %) |
Dec 29 2006 | LIPD | LIPID SCIENCES INC ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 1.45 | 1,050 | 1,523 | 3,714,408 | 3.7 M to 3.7 M (-0.03 %) |
Dec 29 2006 | LIPD | LIPID SCIENCES INC ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 1.44 | 1,700 | 2,448 | 3,715,458 | 3.7 M to 3.7 M (-0.05 %) |
Dec 29 2006 | LIPD | LIPID SCIENCES INC ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 1.43 | 400 | 572 | 3,717,158 | 3.7 M to 3.7 M (-0.01 %) |
Dec 29 2006 | LIPD | LIPID SCIENCES INC ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 1.42 | 2,040 | 2,897 | 3,717,558 | 3.7 M to 3.7 M (-0.05 %) |
Dec 29 2006 | LIPD | LIPID SCIENCES INC ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 1.41 | 2,900 | 4,089 | 3,719,598 | 3.7 M to 3.7 M (-0.08 %) |
Dec 29 2006 | LIPD | LIPID SCIENCES INC ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 1.37 | 1,250 | 1,713 | 3,722,498 | 3.7 M to 3.7 M (-0.03 %) |
Dec 29 2006 | LIPD | LIPID SCIENCES INC ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 1.36 | 2,200 | 2,992 | 3,723,748 | 3.7 M to 3.7 M (-0.06 %) |
Dec 29 2006 | LIPD | LIPID SCIENCES INC ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 1.35 | 24,630 | 33,251 | 3,725,948 | 3.8 M to 3.7 M (-0.66 %) |
Dec 29 2006 | LIPD | LIPID SCIENCES INC ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 1.40 | 12,684 | 17,758 | 3,750,578 | 3.8 M to 3.8 M (-0.34 %) |